I suggest you read the release in August which details the Cho deal. All trials on the cancer treatment are financed by Cho to approval. No more cap raises, other than already announced, unless IVX continues with the respiratory trials. The only announcement about this is that they are trying to sell or partner these assets. That is the only information we have and we should make our assumptions on the published info.
IVX Price at posting:
0.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)